Selective Serotonin Reuptake Inhibitor Toxicity Questions & Answers

1. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991 Jun. 148(6):705-13. [QxMD MEDLINE Link].

2. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005 Mar 17. 352(11):1112-20. [QxMD MEDLINE Link].

3. Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. JAMA. 2002 Jan 9. 287(2):203-9. [QxMD MEDLINE Link].

4. Pirraglia PA, Stafford RS, Singer DE. Trends in Prescribing of Selective Serotonin Reuptake Inhibitors and Other Newer Antidepressant Agents in Adult Primary Care. Prim Care Companion J Clin Psychiatry. 2003 Aug. 5(4):153-157. [QxMD MEDLINE Link]. [Full Text].

5. Lawrence KR, Adra M, Gillman PK. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clin Infect Dis. 2006 Jun 1. 42(11):1578-83. [QxMD MEDLINE Link].

6. Kaplan H, Sadock B. Serotonin-specific reuptake inhibitors. Synopsis of Psychiatry. 8th ed. Williams and Wilkins; 1988. 1083-92.

7. Hirsch M, Birnbaum R. Pharmacology of Antidepressants. UpToDate [serial online]. 2004. v 11.3.:

8. Lane R, Baldwin D. Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol. 1997 Jun. 17(3):208-21. [QxMD MEDLINE Link].

9. Flanagan RJ. Fatal toxicity of drugs used in psychiatry. Hum Psychopharmacol. 2008 Jan. 23 Suppl 1:43-51. [QxMD MEDLINE Link].

10. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol. 1999. 13(1):100-9. [QxMD MEDLINE Link].

11. Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. CMAJ. 2003 May 27. 168(11):1439-42. [QxMD MEDLINE Link].

12. Ener RA, Meglathery SB, Van Decker WA, Gallagher RM. Serotonin syndrome and other serotonergic disorders. Pain Med. 2003 Mar. 4(1):63-74. [QxMD MEDLINE Link].

13. Mason PJ, Morris VA, Balcezak TJ. Serotonin syndrome. Presentation of 2 cases and review of the literature. Medicine (Baltimore). 2000 Jul. 79(4):201-9. [QxMD MEDLINE Link].

14. White N, Litovitz T, Clancy C. Suicidal antidepressant overdoses: a comparative analysis by antidepressant type. J Med Toxicol. 2008 Dec. 4(4):238-50. [QxMD MEDLINE Link]. [Full Text].

15. Klein-Schwartz W, Benson BE, Lee SC, Litovitz T. Comparison of citalopram and other selective serotonin reuptake inhibitor ingestions in children. Clin Toxicol (Phila). 2012 Jun. 50(5):418-23. [QxMD MEDLINE Link].

16. Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol. 2004. 42(3):277-85. [QxMD MEDLINE Link].

17. US Food and Drug Administration. Celexa (citalopram hydrobromide): Drug Safety Communication – Abnormal Heart Rhythms Associated With High Doses. Available at http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm269481.htm. Accessed: August 24, 2011.

18. Celexa (citalopram hydrobromide) [package insert]. St. Louis, Missouri: Forest Pharmaceuticals, Inc. August, 2011. Available at [Full Text].

19. Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol. 2009 Jun. 104(6):1475-82. [QxMD MEDLINE Link].

20. Mowry JB, Spyker DA, Cantilena LR Jr, McMillan N, Ford M. 2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 31st Annual Report. Clin Toxicol (Phila). 2014 Dec. 52 (10):1032-283. [QxMD MEDLINE Link].

21. Dunkley EJ, Isbister GK, Sibbritt D, Dawson AH, Whyte IM. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003 Sep. 96(9):635-42. [QxMD MEDLINE Link].

22. Chechani V. Serotonin syndrome presenting as hypotonic coma and apnea: potentially fatal complications of selective serotonin receptor inhibitor therapy. Crit Care Med. 2002 Feb. 30(2):473-6. [QxMD MEDLINE Link].

23. [Guideline] Nelson LS, Erdman AR, Booze LL, Cobaugh DJ, Chyka PA, Woolf AD, et al. Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007 May. 45(4):315-32. [QxMD MEDLINE Link].

24. Evans CE, Sebastian J. Serotonin syndrome. Emerg Med J. 2007 Apr. 24(4):e20. [QxMD MEDLINE Link]. [Full Text].

25. Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. J Emerg Med. 1998 Jul-Aug. 16(4):615-9. [QxMD MEDLINE Link].

26. Gillman PK. The serotonin syndrome and its treatment. J Psychopharmacol. 1999. 13(1):100-9. [QxMD MEDLINE Link].

27. Nisijima K, Yoshino T, Yui K, Katoh S. Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome. Brain Res. 2001 Jan 26. 890(1):23-31. [QxMD MEDLINE Link].

28. Nisijima K, Yoshino T, Ishiguro T. Risperidone counteracts lethality in an animal model of the serotonin syndrome. Psychopharmacology (Berl). 2000 May. 150(1):9-14. [QxMD MEDLINE Link].

29. Marx J, Hockberger R, Walls R. Rosen's Emergency Medicine. 5th ed. CV Mosby; 2002. 2087-2103.

Tracy A Cushing, MD, MPH, FACEP, FAWM Associate Professor and Attending Physician, Department of Emergency Medicine, University of Colorado School of Medicine

Tracy A Cushing, MD, MPH, FACEP, FAWM is a member of the following medical societies: Society for Academic Emergency Medicine, Wilderness Medical Society

Disclosure: Nothing to disclose.

Theodore I Benzer, MD, PhD Assistant Professor in Medicine, Harvard Medical School; Director of the ED Observation Unit, Director of Toxicology, Chair of Quality and Safety, Department of Emergency Medicine, Massachusetts General Hospital

Theodore I Benzer, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians

Disclosure: Nothing to disclose.

Monica Noori, MD Resident Physician, Department of Emergency Medicine, Denver Health

Monica Noori, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Emergency Medicine Residents' Association

Disclosure: Nothing to disclose.

Michael A Miller, MD Clinical Professor of Emergency Medicine, Medical Toxicologist, Department of Emergency Medicine, Texas A&M Health Sciences Center; CHRISTUS Spohn Emergency Medicine Residency Program

Michael A Miller, MD is a member of the following medical societies: American College of Medical Toxicology

Disclosure: Nothing to disclose.

Howard Kim, MD Resident Physician, Department of Emergency Medicine, Denver Health Medical Center

Disclosure: Nothing to disclose.

John G Benitez, MD, MPH Associate Professor, Department of Medicine, Medical Toxicology, Vanderbilt University Medical Center; Managing Director, Tennessee Poison Center

John G Benitez, MD, MPH is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Emergency Medicine, American College of Medical Toxicology, American College of Preventive Medicine, Society for Academic Emergency Medicine, Undersea and Hyperbaric Medical Society, and Wilderness Medical Society

Disclosure: Nothing to disclose.

Miguel C Fernandez, MD, FAAEM, FACEP, FACMT, FACCT Associate Clinical Professor, Department of Surgery/Emergency Medicine and Toxicology, University of Texas School of Medicine at San Antonio; Medical and Managing Director, South Texas Poison Center

Miguel C Fernandez, MD, FAAEM, FACEP, FACMT, FACCT is a member of the following medical societies: American Academy of Emergency Medicine, American College of Clinical Toxicologists, American College of Emergency Physicians, American College of Medical Toxicology, American College of Occupational and Environmental Medicine, Society for Academic Emergency Medicine, and Texas Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

• Print this section
• Print the entire contents of
• Print the entire contents of article